行情

DSS

DSS

Document安全系统
AMEX

实时行情|Nasdaq Last Sale

0.3840
+0.0140
+3.78%
盘后: 0.3899 +0.0059 +1.54% 19:32 05/16 EDT
开盘
0.3975
昨收
0.3700
最高
0.3975
最低
0.3840
成交量
14.22万
成交额
0
52周最高
3.050
52周最低
0.3300
市值
3,249.67万
市盈率(TTM)
-0.5702
分时
5日
1月
3月
1年
5年
DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®
ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculate...
GlobeNewswire · 05/06 12:30
DSS: DSS Starts to Generate Revenues From New Ventures and Hits Cash Flow Breakeven in Q4
By Lisa Thompson NYSE:DSS READ THE FULL DSS RESEARCH REPORT
Benzinga · 04/12 14:52
94 Biggest Movers From Friday
Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.
Benzinga · 03/14 08:52
Executives Buy Over $1.5M Of 4 Penny Stocks
All major European indices regained ground on Friday. Investors, meanwhile, focused on some notable insider trades When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interes...
Benzinga · 03/11 12:49
Insider Buy: Dss
MT Newswires · 03/11 06:27
68 Biggest Movers From Friday
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday.
Benzinga · 03/07 09:49
24 Stocks Moving in Friday's Pre-Market Session
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 30.4% to $0.9520 in pre-market trading. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for investigational treatment of long-haul COVID-19.
Benzinga · 03/04 11:48
BRIEF-Impact Biomedical's Proprietary Equivir Compound To Treat Viral Infection Receives Clean Patentability Report From World Intellectual Property Organization's Isa Division
reuters.com · 03/03 15:43
更多
暂无数据
了解DSS最新的财务预测,通过DSS每股收益,每股净资产,每股现金流等数据分析Document安全系统近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测DSS价格均价为3.000,最高价位3.000,最低价为3.000。
最高3.000
均价3.000
最低3.000
现价0.3840
EPS
实际EPS
预期EPS
-0.24-0.18-0.12-0.06
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
机构持股
总机构数: 20
机构持股: 65.80万
持股比例: 0.78%
总股本: 8,462.68万
类型机构数股数
增持
2
2.84万
建仓
4
15.78万
减持
6
14.21万
平仓
3
151
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
纸包装
+0.34%
容器和包装
+0.99%
高管信息
Chairman/Director
Heng Fai Chan
Chief Executive Officer/Director
Frank Heuszel
Chief Financial Officer
Todd Macko
Chief Operating Officer
Jason Grady
Lead Director/Independent Director
John Thatch
Director
Tung Moe Chan
Independent Director
Jose Escudero
Independent Director
Sassuan Lee
Independent Director
Wai Leung Wu
暂无数据
暂无数据
DSS 简况
DSS, Inc., formerly Document Security Systems, Inc., is a developer and marketer of secure technologies. The Company is focused on blockchain security, direct marketing, healthcare, consumer packaging, real estate and securitized digital assets. It is engaged in providing solutions to protect corporations, financial institutions, and governments from counterfeiting and fraud. The Company through its subsidiaries operates in various business lines, which include direct marketing or online sales group, premier packaging, Internet protocol (IP) technology, biohealth group, securities and fintech group, energy group, secure living, and blockchain technology. Its segments include Direct Marketing or Online Sales Group, Premier Packaging and IP Technology. Its Direct Marketing segment is engaged in providing services to assist companies in the gig business model. Its Premier Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets.

微牛提供DSS Inc(AMEX-DSS)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的DSS股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易DSS股票基本功能。